Urothelial Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer [Phase 3]
This entry reports a Phase 3 trial of UGN-103 for low-grade, intermediate-risk non-muscle invasive bladder cancer and indicates the study is…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1]
A Phase 1 dose-escalation study of UGN-301 in patients with recurrent non-muscle invasive bladder cancer has been completed.
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
Clinical trial update on Bladder CARE™, a non-invasive urine test designed to detect bladder cancer in inconclusive cases.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
A Mayo Clinic-sponsored study evaluating ultrasound-guided core needle biopsy to stage urothelial carcinoma of the bladder is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection [Phase 2, Phase 3]
A completed Phase 2/3 trial from Ain Shams University investigated whether the osmolarity of postoperative irrigation fluids influences the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy [Phase 2]
Phase 2 trial evaluating futibatinib in combination with durvalumab prior to cystectomy for patients with muscle-invasive bladder cancer ine…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab [Phase 2]
A Phase 2 basket trial evaluating the combination of niraparib and dostarlimab across multiple cancers has been terminated.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients [NA]
A clinical trial update describing Hyperthermic Intravesical Chemotherapy (HIVEC) for high-grade non-muscle invasive bladder cancer that is …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy [NA]
Clinical trial entry from Johns Hopkins University recruiting to study home intravenous fluid infusion after radical cystectomy for bladder …
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial update describes neoadjuvant sasanlimab with radiation as an in situ vaccine for cisplatin-ineligible muscle invasi…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer [NA]
A Phase II trial evaluating an organ-conserving radiochemotherapy approach for muscle-invasive bladder cancer has been terminated, with resu…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder [Phase 2]
Phase 2 trial of docetaxel in combination with lapatinib for metastatic transitional cell carcinoma of the bladder was terminated with resul…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder [Phase 2]
Phase 2 clinical trial update evaluating pembrolizumab with gemcitabine and concurrent hypofractionated radiation therapy for muscle-invasiv…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating infusion of NY-ESO-1–specific TCR-engineered lymphocytes in patients with NY-ESO-1-expressing…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study [Phase 2]
This update describes an open-label, randomized Phase 2 trial evaluating toripalimab with or without sequential intravesical gemcitabine-mit…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy [Phase 2]
Phase 2 clinical trial evaluating a decision-support tool to select women for gynecologic-sparing radical cystectomy in urothelial carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Intervention of Bladder Cancer by CAR-T [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a CAR-T cell therapy for bladder cancer (urothelial carcinoma of the bladder) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Efficacy and Safety of Two Bladder-preserving Treatment Durations With Disitamab Vedotin Plus Toripalimab Combination in Her2-expressing Muscle-invasive Bladder Cancer: A Phase II, Open-Label, Randomized Clinical Trial [Phase 2]
This Phase II, open-label, randomized trial assesses two bladder-preserving durations of Disitamab Vedotin plus Toripalimab in HER2-expressi…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection [Phase 2]
Phase 2 trial assessing Disitamab Vedotin combined with a PD-1 inhibitor and radiotherapy as a bladder-preserving treatment for localized HE…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating AM80 in combination with gemcitabine, cisplatin, and nivolumab for urothelial carcinoma; recruitment …
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma [Phase 2]
A Phase 2 clinical trial evaluated primary excision with preoperative neoadjuvant and adjuvant therapy for oligometastatic urothelial carcin…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: MICROBIOTA AND BLADDER CANCER [NA]
This clinical trial update describes a study on the microbiota and bladder cancer sponsored by Centre Hospitalier Universitaire de Nice. The…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. [Phase 1, Phase 2]
This clinical trial explores a tumor immune biomarker-guided strategy to improve response to Bacillus Calmette-Guérin (BCG) therapy in high-…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction [Phase 1, Phase 2]
Clinical trial update on eribulin mesylate in patients with locally advanced or metastatic urothelial carcinoma of the bladder, including th…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder [NA]
This clinical trial update reports that the study evaluating cystoscopic evaluation to predict pT0 urothelial carcinoma of the bladder is cu…